On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...

New Treatments for HR-Positive Breast Cancer and Mantle Cell Lymphoma Offer Promising Outcomes and Expanded Options for ...

Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way ...

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

If you have been diagnosed with metastatic breast cancer, resources like support groups, counseling, financial assistance, and online communities can help.

The number of cancer cases is expected to cross the two million mark in 2024 — the first time ever — according American Cancer Society estimates.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Arkansas’ own statistics show much work to be done. Per a 2023 press release from the Arkansas Department of Health, nearly ...

“We are living in the dark ages,” said Robyn Spoon, a member of the coalition and CEO of Elevate Childhood Cancer Research ...

Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...